OpenAI has published a framework for using AI to strengthen biological resilience and defense capabilities. The document outlines how large language models can accelerate disease surveillance, therapeutics development, and pandemic preparedness while establishing guardrails against misuse. This addresses the dual-use risk inherent in making advanced AI accessible for biological research.

What This Means for Your Business

Pharmaceutical, biotech, and public health organizations should review this framework to understand how AI can accelerate your research and defense capabilities. Organizations working on infectious disease, pandemic preparedness, or biosecurity should begin evaluating OpenAI's recommendations as a baseline for responsible AI deployment in sensitive domains. This will likely inform regulatory expectations for AI use in biotech.